Skip Navigation

European Heart Journal 2002 23(23):1867-1876; doi:10.1053/euhj.2002.3255
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (64)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hobbs, F.D.R.
Right arrow Articles by Davies, M.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hobbs, F.D.R.
Right arrow Articles by Davies, M.K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Impact of heart failure and left ventricular systolic dysfunction on quality of life. A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population

F.D.R. Hobbsa,f1, J.E. Kenkrea, A.K. Roalfea, R.C. Davisa, R. Harea and M.K. Daviesb

a Department of Primary Care and General Practice, Primary Care Clinical Sciences Building, University of Birmingham, Birmingham, U.K.
b Department of Cardiology, Selly Oak Hospital, Birmingham, U.K.

revised March 25, 2002; accepted March 27, 2002

Abstract

Background Heart failure and left ventricular systolic dysfunction (LVSD) are increasingly common disorders, with outcomes worse than many cancers. Evidence-based therapies, such as ACE inhibitors and beta-blockers, improve prognosis and symptoms, and reduce healthcare expenditure. However, despite the high prevalence and malignant prognosis, few studies have reported the impact of heart failure and LVSD on overall quality of life and, more crucially, have not researched the elderly or those in the community.

Methods All patients attending the Echocardiographic Heart of England Screening (ECHOES) study of the prevalence of heart failure and LVSD in the community were assessed by clinical history and examination, electrocardiogram and echocardiography, and also completed the SF36 health status questionnaire. Quality of life in patients found to have heart failure, LVSD, and other cardiac and medical conditions are compared with the randomly selected general population sample. Data are generalisable to the UK.

Results 6162 people in the community were screened in the ECHOES study, of whom 5961 (97%) completed the SF36. The health perceptions of 3850 people aged 45 years or older selected randomly from the population were compared with those of 426 patients diagnosed as having definite heart failure. Those with heart failure had significant impairment of all the measured aspects of physical and mental health, in addition to declines in physical functioning. Significantly worse impairment was found in those with more severe heart failure by NYHA class: indeed, NYHA functional class was closely correlated to SF36 score. Patients with asymptomatic left ventricular dysfunction and patients rendered asymptomatic by treatment had similar scores to the random population sample. Those with heart failure reported more severe physical impairment of quality of life than people giving a history of chronic lung disease or arthritis, with less impact on mental health than patients reporting depression.

Conclusions Patients with heart failure have statistically significant impairment of all aspects of quality of life, not simply physical functioning. The physical (role and functioning) health burden was significantly greater than that suffered in other serious common chronic disorders, whether cardiac or other systems. Optimising treatment to improve NYHA class appears to improve perceptions of quality of life for patients with heart failure. Given the dramatic decline in quality of life with heart failure, this end-point should be a much more important target for healthcare interventions, especially treatments such as ACE inhibitors and beta-blockers that are shown to improve quality of life. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved

Key Words: Heart failure, LVSD, quality of life.

f1 Correspondence: F. D. R. Hobbs, Department of Primary Care and General Practice, Primary Care Clinical Sciences Building, University of Birmingham, Birmingham B15 2TT, U.K.

References

  1. Davies MK, Hobbs FDR, Davis RC. Prevalence of left ventricular systolic dysfunction and heart failure in the general population: main findings from the ECHOES (Echocardiographic Heart of England Screening) Study. Lancet. 2001;358:439–445[CrossRef][ISI][Medline]
  2. Bonneaux L, Barendregt JJ, Meeter K, Bonsel GJ, van der Maas PJ. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Pub Health. 1994;84:20–28[Abstract/Free Full Text]
  3. Hobbs FDR, Davis RC, McLeod S. Prevalence of heart failure in ‘high risk’ groups. J Am Coll Cardiol. 1998;31:85C
  4. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107–115[Abstract/Free Full Text]
  5. Calkins DR, Rubenstein LV, Cleary PD. Failure of physicians to recognize functional disability in ambulatory patients. Ann Int Med. 1991;114:451–454[ISI][Medline]
  6. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450–1456[Abstract/Free Full Text]
  7. Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP. Beta-blockers in heart failure: meta-analysis of randomized trials. Circulation. 1998;98:1184–1191[Abstract/Free Full Text]
  8. Rogers WJ, Johnstone DE, Yusuf S. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1994;23:393–400[Abstract]
  9. N Engl J Med. 1991;325:293–302[Abstract]
  10. N Engl J Med. 1992;327:685–691[Abstract]
  11. Jenkinson C, Jenkinson D, Shepperd S, Layte R, Peterson S. Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). Age Ageing. 1997;26:7–13[Abstract/Free Full Text]
  12. Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 1991;12:315–321[Abstract/Free Full Text]
  13. Willenheimer R, Erhardt L, Cline C, Rydberg E, Israelsson B. Exercise training in heart failure improves quality of life and exercise capacity. Eur Heart J. 1998;19:774–781[Abstract/Free Full Text]
  14. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190–1195[Abstract/Free Full Text]
  15. Doba N, Tomiyama H, Nakayama T. Drugs, heart failure and quality of life: what are we achieving? What should we be trying to achieve? Drugs Aging. 1999;14:153–163[CrossRef][ISI][Medline]
  16. Krumholz HM, Baker DW, Ashton CM. Evaluating quality of care for patients with heart failure. Circulation. 2000;101:122–140[Abstract/Free Full Text]
  17. Rector TS, Tschumperlin LK, Kubo SH. Using the living with heart failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Cardiac Failure. 1995;1:201–206[CrossRef][Medline]
  18. Konstam V, Salem D, Pouleur H. Baseline quality of life as a predictor of mortality and hospitalization in 5025 patients with congestive heart failure. Am J Cardiol. 1996;78:890–895[CrossRef][ISI][Medline]
  19. Stewart AL, Greenfield S, Hays RD. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. JAMA. 1989;262:907–913[Abstract]
  20. Cline CM, Willenheimer RB, Erhardt LR, Wiklund I, Israelsonn BY. Health related quality of life in elderly patients with heart failure. Scand Cardiol J. 1999;33:278–285
  21. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol. 1999;84:348–350[CrossRef][ISI][Medline]
  22. Murberg TA, Bru E, Svebak S, Tveteras R, Aarsland T. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: a two-years follow-up study. Int J Psych Med. 1999;29:311–326[CrossRef][ISI][Medline]
  23. Eur Heart J. 1995;16:741–751[Free Full Text]
  24. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483[ISI][Medline]
  25. Donovan JL, Frankel SJ, Eyles JD. Assessing the need for health status measures. J Epidem Community Health. 1993;47:158–162[ISI][Medline]
  26. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334[CrossRef][ISI]
  27. Hunt SM, McEwen J, McKenna SP. Measuring health status. Beckenham: Croom Helm; 1986.
  28. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute; 1994.
  29. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use in the NHS? Br Med J. 1993;306:1440–1444[ISI][Medline]
  30. SAS Institute Inc, SAS/STAT® User's guide, Cary, NC, SAS Institute Inc. 1989
  31. Brown N, Melville M, Gray D. Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart. 1999;81:352–358[Abstract/Free Full Text]
  32. Rogers WJ, Johnstone DE, Yusuf S. Quality of life among 5025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1994;23:393–400[Abstract]
  33. Jenkinson C, Jenkinson D, Shepperd S, Layte R, Peterson S. Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). Age Ageing. 1997;26:7–13[Abstract/Free Full Text]
  34. Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 1991;12:315–321[Abstract/Free Full Text]
  35. Cowley AJ, Skene AM. Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators. Br Heart J. 1994;72:226–230[Abstract/Free Full Text]
  36. Cohen J. Statistical power analysis for the behavioural sciences. New Jersey: Lawrence Erlbaum Associates; 1988.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EuropaceHome page
J. B. Johansen, S. S. Pedersen, H. Spindler, K. Andersen, J. C. Nielsen, and P. T. Mortensen
Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients
Europace, May 1, 2008; 10(5): 545 - 551.
[Abstract] [Full Text] [PDF]

Home page
 Crit Care NurseHome page
S. A. Thomas, D. W. Chapa, E. Friedmann, C. Durden, A. Ross, M. C. Y. Lee, and H.-J. Lee
Depression in Patients With Heart Failure: Prevalence, Pathophysiological Mechanisms, and Treatment
Crit. Care Nurse, April 1, 2008; 28(2): 40 - 55.
[Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
M. J Johnson
Management of end stage cardiac failure
Postgrad. Med. J., June 1, 2007; 83(980): 395 - 401.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
F.D. R. Hobbs, A. K. Roalfe, R. C. Davis, M. K. Davies, R. Hare, and and the Midlands Research Practices Consortium (Mi
Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES)
Eur. Heart J., May 1, 2007; 28(9): 1128 - 1134.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
J. J.V. McMurray, F. L. Andersson, S. Stewart, K. Svensson, A. C. Solal, R. Dietz, J. Vanhaecke, D. J. van Veldhuisen, J. Ostergren, C. B. Granger, et al.
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
Eur. Heart J., June 1, 2006; 27(12): 1447 - 1458.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
M. Marty, M. Espie, A. Llombart, A. Monnier, B. L. Rapoport, V. Stahalova, and On behalf of the Dexrazoxane Study Group
Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane(R)) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy
Ann. Onc., April 1, 2006; 17(4): 614 - 622.
[Abstract] [Full Text] [PDF]

Home page
 Age AgeingHome page
M. Gott, S. Barnes, C. Parker, S. Payne, D. Seamark, S. Gariballa, and N. Small
Predictors of the quality of life of older people with heart failure recruited from primary care
Age Ageing, March 1, 2006; 35(2): 172 - 177.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
W. J. Remme, J. J.V. McMurray, B. Rauch, F. Zannad, K. Keukelaar, A. Cohen-Solal, J. Lopez-Sendon, F.D. R. Hobbs, D. E. Grobbee, A. Boccanelli, et al.
Public awareness of heart failure in Europe: first results from SHAPE
Eur. Heart J., November 2, 2005; 26(22): 2413 - 2421.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. Razvi, L. E Ingoe, C. V McMillan, and J. U Weaver
Health status in patients with sub-clinical hypothyroidism
Eur. J. Endocrinol., May 1, 2005; 152(5): 713 - 717.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. A. Incalzi, A. Corsonello, C. Pedone, F. Corica, P. Carbonin, R. Bernabei, and on Behalf of the GIFA Investigators
Construct Validity of Activities of Daily Living Scale: A Clue To Distinguish the Disabling Effects of COPD and Congestive Heart Failure
Chest, March 1, 2005; 127(3): 830 - 838.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. M. O'Connor and K. E. Joynt
Depression: are we ignoring an important comorbidity in heart failure?
J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1550 - 1552.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
V. E. Hagens, A. V. Ranchor, E. Van Sonderen, H. A. Bosker, O. Kamp, J. G. P. Tijssen, J. H. Kingma, H. J. G. M. Crijns, I. C. Van Gelder, and the RACE Study Group
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation: Results from the Rate Control Versus Electrical Cardioversion (RACE) study
J. Am. Coll. Cardiol., January 21, 2004; 43(2): 241 - 247.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
A B Rao and D Gray
Breathlessness in hospitalised adult patients
Postgrad. Med. J., December 1, 2003; 79(938): 681 - 685.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M Thulasimani and M Ramaswamy
Suggestions to improve the quality of life in heart failure
Eur. Heart J., September 2, 2003; 24(18): 1700 - 1700.
[Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
T. Murray-Thomas and M. R Cowie
Epidemiology and clinical aspects of congestive heart failure
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2003; 4(3): 131 - 136.
[Abstract] [PDF]

Home page
 Eur Heart JHome page
R. Archana and D. Gray
The quality of life in chronic disease--heart failure is as bad as it gets
Eur. Heart J., December 1, 2002; 23(23): 1806 - 1808.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (64)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hobbs, F.D.R.
Right arrow Articles by Davies, M.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hobbs, F.D.R.
Right arrow Articles by Davies, M.K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?